Nissan Medical Industries Ltd (TLV:NISA)

Nissan Medical Industries Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	86	83	116	98	78	199
Market Cap Growth	-6.44%	-28.12%	18.15%	25.68%	-60.78%	-23.34%
Enterprise Value	360	363	413	431	433	525
Last Close Price	9.31	9.17	10.78	8.67	6.90	17.26

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	12.22	19.97	14.66	17.37	-	5.53
PS Ratio	0.14	0.13	0.18	0.13	0.11	0.30
PB Ratio	0.29	0.27	0.33	0.28	0.24	0.58
P/TBV Ratio	0.56	0.53	0.60	0.51	0.44	1.18
P/FCF Ratio	2.68	2.28	5.59	1.02	31.30	20.27
P/OCF Ratio	1.33	1.33	4.32	0.93	6.69	11.07

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.59	0.56	0.62	0.59	0.63	0.79
EV/EBITDA Ratio	6.69	7.49	7.79	4.66	16.09	5.75
EV/EBIT Ratio	13.01	14.08	13.92	7.02	-	7.98
EV/FCF Ratio	11.36	9.94	19.91	4.49	173.44	53.48

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.61	0.62	0.57	0.56	0.76	0.70
Debt / EBITDA Ratio	3.32	3.54	3.41	2.14	9.34	2.63
Debt / FCF Ratio	5.66	5.20	9.76	2.07	100.67	24.53
Net Debt / Equity Ratio	0.56	0.56	0.52	0.49	0.70	0.58
Net Debt / EBITDA Ratio	3.38	3.55	3.50	1.87	8.61	2.20
Net Debt / FCF Ratio	5.21	4.71	8.93	1.81	92.85	20.44
Asset Turnover	0.97	0.99	0.94	1.02	0.93	0.93
Inventory Turnover	4.28	3.98	3.98	5.40	5.66	6.44
Quick Ratio	0.46	0.44	0.38	0.62	0.66	0.74
Current Ratio	0.98	0.99	1.11	1.16	1.17	1.34
Return on Equity (ROE)	4.56%	2.63%	3.89%	5.54%	-13.99%	17.11%
Return on Assets (ROA)	2.77%	2.44%	2.62%	5.32%	-0.15%	5.75%
Return on Invested Capital (ROIC)	5.07%	4.39%	5.06%	7.70%	-0.32%	10.07%
Return on Capital Employed (ROCE)	7.30%	6.50%	6.50%	12.70%	-0.30%	12.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	8.59%	5.01%	6.82%	5.76%	-46.18%	18.09%
FCF Yield	37.35%	43.84%	17.90%	97.75%	3.19%	4.93%
Dividend Yield	19.26%	19.84%	5.88%	-	-	2.01%
Payout Ratio	227.46%	396.17%	86.17%	-	-	25.22%
Total Shareholder Return	10.11%	19.84%	5.88%	-	-	2.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error